Vergoeding 2017-2021 voor ATC-subgroep J02AC : Triazoolderivaten
- Raming voor de totale Zvw-populatie
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| J02AC01 Fluconazol (Diflucan ®) | 701.260 | 674.940 | 757.980 | 720.190 | 667.530 |
| J02AC02 Itraconazol (Trisporal ®) | 1.720.400 | 1.800.800 | 1.627.900 | 1.274.000 | 1.174.000 |
| J02AC03 Voriconazol (Vfend ®) | 1.201.000 | 800.370 | 655.340 | 560.110 | 430.100 |
| J02AC04 Posaconazol (Noxafil ®) | 5.239.200 | 6.118.500 | 6.751.400 | 5.074.100 | 3.305.700 |
| J02AC05 Isavuconazol (Cresemba ®) | . | 76.468 | 834.370 | 1.024.000 | 841.840 |
| Totaal | 8.861.860 | 9.471.078 | 10.626.990 | 8.652.400 | 6.419.170 |